1Does being female provide a neuroprotective advantage following spinal cord injury?INVITED REVIEWS1533-1536
2Ischemic long-term-potentiation (iLTP): perspectives to set the threshold of neural plasticity toward therapyINVITED REVIEWS1537-1539
3Delayed peripheral nerve repair: methods, including surgical ‘cross-bridging' to promote nerve regenerationINVITED REVIEWS1540-1544
4Neuroprotection and recovery from early-life adversity: considerations for environmental enrichmentHIGHLIGHTS1545-1547
5The emerging roles of transplanted radial glial cells in regenerating the central nervous systemHIGHLIGHTS1548-1551
6Targeting α7 nicotinic acetylcholine receptors: a future potential for neuroprotection from traumatic brain injuryHIGHLIGHTS1552-1554
11Exosomes in neurological disease, neuroprotection, repair and therapeutics: problems and perspectivesPERSPECTIVES1565-1567
12Superparamagnetic iron oxide nanoparticles: promote neuronal regenerative capacity?PERSPECTIVES1568-1569
15Insights of the brain damage response using antibodies identifying surface antigens on neural stem cells and neuroblastsPERSPECTIVES1574-1575
16Glypican 4 down-regulation in pluripotent stem cells as a potential strategy to improve differentiation and to impair tumorigenicity of cell transplantsPERSPECTIVES1576-1577
17Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?PERSPECTIVES1578-1580
19Myelin morphology and axon pathology in demyelination during experimental autoimmune encephalomyelitisPERSPECTIVES1584-1585
20Gene therapy for Parkinson's disease: a decade of progress supported by posthumous contributions from volunteer subjectsPERSPECTIVES1586-1588
